List of Top Websites on Biopharma

Biotech and Pharma Industry News | BioPharma Dive. BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.

Triangulum Biopharma. Triangulum Biopharma

Health Biotechnology and Biopharma Journal. HBB Journal is a Quarterly peer-reviewed, which publishes research papers, review articles and short communications on all areas of Biotechnology, Biopharma and Health.

GVB Biopharma | Hemp Extraction & White Label. GVB Biopharma operates two state-of-the-art hemp extraction and white labeling facilities in Central Oregon and Las Vegas, Nevada.

Sartorius | Biopharma, Laboratory, Applied & Life Sciences. Sartorius offers solutions for the biopharmaceutical industry and laboratories, from drug discovery and development to production platforms for biomanufacturing.

Active Pharmaceutical Ingredient Suppliers, Manufacturers - Manus Aktteva BioPharma LLP. Manus Aktteva Biopharma is leading suppliers for Active Pharmaceutical Ingredient (API) development and Chemical formulation research. We offer more than 100+ pharmaceutical intermediates.

Pharmaceutical Commerce Magazine | For Pharma Industry Executives. Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more. Audited by BPA Worldwide.

UCB | Inspired by patients. Driven by science.. With a unique combination of expertise in biology and chemistry, UCB is a global biopharma focusing on severe diseases in two therapeutic areas – CNS and Immunology.

CinnaGen. CinnaGen Co. was founded in 1994 with the goal of manufacturing hi-tech products in biotechnology and related fields. Since its start of operation with 4 scientists, CinnaGen has grown to become the biggest bio-pharmaceutical manufacturer and biotech exporter in the region. The concept was to be active in the research and development of new potent biotech-based products to cover regional markets. Enzymes, molecular biology reagents and PCR kits were the first products and then CinnaGen used its proprietary set of technologies to endow monoclonal antibodies for blood group typing. The next important step for CinnaGen was to enter therapeutic recombinant protein and monoclonal anti-bodies area. Today the company prides itself in its innovative skills meeting today challenges. We focus our efforts on developing the bio-similar candidates in the areas of immunological diseases, infertility, hormone disorders and oncology as well as providing contract research development services. The company is spending over 20 percent of its total turnover on R&D activities. CinnaGen is strategically positioned to become and remain a leading biotechnology company in the region. Our aim is to use our expertise to identify and acquire selected products through strategic partnerships to promote sustainable development in human health.